SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-020102
Filing Date
2024-06-12
Accepted
2024-06-12 16:48:20
Documents
14
Period of Report
2024-06-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K omer20240516_8k.htm   iXBRL 8-K 56480
  Complete submission text file 0001437749-24-020102.txt   191389

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA omer-20240606.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omer-20240606_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20240606_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20240606_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT omer20240516_8k_htm.xml XML 2851
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 241039000
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)